We can do this because tumor blood vessels are unlike normal, healthy vessels we see in other places of the body -- they're abnormal, they're very poorly constructed, and because of that, they're highly vulnerable to treatments that target them.
To možemo učiniti zato što se tumorske krvne žile razlikuju od normalnih, zdravih krvnih žila koje susrećemo u ostalim dijelovima tijela: one su abnormalne, loše građene i zahvaljujući tome, iznimno ranjive na terapiju usmjerenu protiv njih.